Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease-Reference-Cited by-同舟云学术

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease

Published:2012-03-14 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Rolinski Michal¹,Fox Chris²,Maidment Ian³,McShane Rupert⁴

Affiliation:

1. Nuffield Department of Clinical Neurosciences; Level 6, West Wing John Radcliffe Hospital Oxford UK OX3 9DU

2. Norwich Medical School; University of East Anglia Norwich UK

3. Kent and Medway NHS and Social Care Partnership Trust; Pharmacy Department; St Martin's Hospital Littlebourne Road Canterbury Kent UK

4. University of Oxford; Radcliffe Department of Medicine; John Radcliffe Hospital Level 4, Main Hospital, Room 4401C Oxford Oxfordshire UK OX3 9DU

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD006504.pub2/fullpdf

Reference116 articles.

1. Donepezil for cognitive impairment in Parkinson's disease: a randomized control trial;Aarsland;Journal of Neurology, Neurosurgery, and Psychiatry,2002

2. Dubois B Tolosa E Kulisevsky J Reichman H Jones R Burn D Efficacy and safety of donepezil in the treatment of Parkinson's disease patients with dementia Alzheimer's and Parkinson's Disease Congress, Salzburg 2007

3. Burn D Emre M McKeith I Reponse to rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease (EXPRESS study group) 57th Annual meeting American Academy of Neurology April 2005

4. Burn D Emre M McKeith I De Deyn PP Aarsland D Hsu C Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease Movement Disorders 2006 1899 907

5. Dujardin K Devos D Duhem S Destee A Marie R-M Durif F Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease Journal of Neurology 2006 1154 9

Cited by 282 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson’s disease: new spotlights on diagnostic procedures and non-pharmacological interventions;Journal of Neurology;2024-08-09

2. CHOLINESTERASE AND TYROSINASE INHIBITORY ACTIVITY OF SUBCRITICAL WATER AND MICROWAVE EXTRACTS OF RAPHANUS SATIVUS L. ‘RED MEAT’ RADIX;Ankara Universitesi Eczacilik Fakultesi Dergisi;2024-07-25

3. Cognition and Activity of Daily Living Function in people with Parkinson’s disease;Journal of Neural Transmission;2024-07-08

4. Technology-based group exercise interventions for people living with dementia or mild cognitive impairment: A scoping review;PLOS ONE;2024-06-13

5. The effect of anticholinergic drugs on cognition of patients with Parkinson’s disease: a cohort study from the Egyptian population;Expert Review of Clinical Pharmacology;2024-05-30